ES524375A0 - Un procedimiento para preparar un compuesto de nitrato piridilalquilico - Google Patents

Un procedimiento para preparar un compuesto de nitrato piridilalquilico

Info

Publication number
ES524375A0
ES524375A0 ES524375A ES524375A ES524375A0 ES 524375 A0 ES524375 A0 ES 524375A0 ES 524375 A ES524375 A ES 524375A ES 524375 A ES524375 A ES 524375A ES 524375 A0 ES524375 A0 ES 524375A0
Authority
ES
Spain
Prior art keywords
piridylalkyl
preparing
procedure
nitrate compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES524375A
Other languages
English (en)
Other versions
ES8502088A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES8502088A1 publication Critical patent/ES8502088A1/es
Publication of ES524375A0 publication Critical patent/ES524375A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
ES524375A 1982-07-26 1983-07-22 Un procedimiento para preparar un compuesto de nitrato piridilalquilico Granted ES524375A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8221592 1982-07-26

Publications (2)

Publication Number Publication Date
ES8502088A1 ES8502088A1 (es) 1984-12-16
ES524375A0 true ES524375A0 (es) 1984-12-16

Family

ID=10531922

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524375A Granted ES524375A0 (es) 1982-07-26 1983-07-22 Un procedimiento para preparar un compuesto de nitrato piridilalquilico

Country Status (17)

Country Link
US (2) US4540701A (es)
EP (1) EP0100081B1 (es)
JP (1) JPS5951263A (es)
KR (1) KR900005470B1 (es)
AT (1) ATE40948T1 (es)
AU (1) AU565791B2 (es)
CA (1) CA1216850A (es)
DE (1) DE3379255D1 (es)
DK (1) DK311683A (es)
ES (1) ES524375A0 (es)
FI (1) FI832490L (es)
GR (1) GR78629B (es)
HU (1) HU190497B (es)
NO (1) NO832700L (es)
PH (1) PH18083A (es)
SU (1) SU1189337A3 (es)
ZA (1) ZA835048B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6081166A (ja) * 1983-10-11 1985-05-09 Fujisawa Pharmaceut Co Ltd 2−ニトロオキシメチル−6−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
JPS6215A (ja) * 1985-02-26 1987-01-06 Fujisawa Pharmaceut Co Ltd 2−ニトロオキシメチル−6−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤
ZA885069B (en) * 1987-07-24 1989-03-29 Fujisawa Pharmaceutical Co Sustained-release percutaneous preparations
JPH02167279A (ja) * 1988-09-30 1990-06-27 Taisho Pharmaceut Co Ltd アポビンカミン酸誘導体
US5047543A (en) * 1988-11-24 1991-09-10 Taisho Pharmaceutical Co., Ltd. 1,4-dihydropyridine derivatives
CN106318877A (zh) * 2016-08-29 2017-01-11 刘翔 一种从茯砖茶中分离、纯化冠突散囊菌及其液态培养方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275642A (en) * 1962-04-26 1966-09-27 Bard Pharmaceutical Inc 3-pyridine carbinol nitrate and its preparation
US3689494A (en) * 1971-03-31 1972-09-05 William R J Simpson N-pyridinealkyl-alkanolamine nitrates

Also Published As

Publication number Publication date
US4540701A (en) 1985-09-10
DE3379255D1 (en) 1989-04-06
AU1663583A (en) 1984-02-02
FI832490L (fi) 1984-01-27
KR840005426A (ko) 1984-11-12
US4613608A (en) 1986-09-23
SU1189337A3 (ru) 1985-10-30
DK311683D0 (da) 1983-07-05
GR78629B (es) 1984-09-27
ZA835048B (en) 1984-03-28
HU190497B (en) 1986-09-29
NO832700L (no) 1984-02-06
ATE40948T1 (de) 1989-03-15
FI832490A0 (fi) 1983-07-07
CA1216850A (en) 1987-01-20
PH18083A (en) 1985-03-18
EP0100081A3 (en) 1985-05-02
ES8502088A1 (es) 1984-12-16
AU565791B2 (en) 1987-10-01
JPS6350343B2 (es) 1988-10-07
EP0100081B1 (en) 1989-03-01
JPS5951263A (ja) 1984-03-24
EP0100081A2 (en) 1984-02-08
KR900005470B1 (ko) 1990-07-30
DK311683A (da) 1984-01-27

Similar Documents

Publication Publication Date Title
ES539446A0 (es) Un procedimiento para preparar un derivado de dihidropiridazinona
ES8204739A1 (es) Un procedimiento para preparar compuestos de cefem
MY101891A (en) Novel carbostyril derivative and process for preparing same.
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
GB8530602D0 (en) Heterocyclic compounds
ES8404360A1 (es) Un procedimiento para preparar compuestos de cefem.
ES524375A0 (es) Un procedimiento para preparar un compuesto de nitrato piridilalquilico
ES8303398A1 (es) Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida.
DE3380517D1 (en) New compounds, pharmaceutical preparations containing same and process for their preparation
ES8702392A1 (es) Un procedimiento para preparar compuestos heterociclicos, en particular compuestos con un anillo de tiadiazinona
DE3362876D1 (en) Dibenzocycloheptenylidene compounds for use in modulating the immune response
GR81759B (es)
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
ES546646A0 (es) Un procedimiento para preparar un compuesto relacionado con arfamenina
DE3261643D1 (en) New peptide, process for preparation thereof and use thereof
ES8307790A1 (es) Un procedimiento para preparacion de 3-(2-(4-piperidil)-1-alquiletil) indoles.
ZW2885A1 (en) Quinate salts of the antimalarial compound meeloquine